Skip to main content
Clinical Trials/CTRI/2021/05/033725
CTRI/2021/05/033725
Completed
Phase 2

Evaluation of Postoperative Analgesia with Intrathecal Morphine after Laparoscopic or Robotic Nephrectomy

Anshuman Sarkar0 sites62 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Anshuman Sarkar
Enrollment
62
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Anshuman Sarkar

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who will undergo elective laparoscopic or robotic radical nephrectomy
  • 2\.American society of Anaesthesiology Physical Score\- I\-III

Exclusion Criteria

  • 1\. Emergency surgery
  • 2\. Conversion to open procedure
  • 3\. Contraindications to spinal anaesthesia (Paient refusal,spinal deformities,local site infection, severe aortic stenosis, increased intrcranial pressure)
  • 4\. Contraindications to study medication (allergy to Morphine, Bupivacaine)
  • 5\. Body mass Index more than 30 kg/m2 or those with documented obstructive sleep apnoea
  • 6\. Patients with life threatening arrhythmias
  • 7\. Patients with left ventricular ejection fraction \<40%
  • 8\. Acute myocardial infarction (within 30 days)
  • 9\. Acute pulmonary edema (within 7 days)
  • 10\. Chronic obstructive pulmonary disease with a forced expiratory volume (FEV1\) in the first second of expiration \<50%

Outcomes

Primary Outcomes

Not specified

Similar Trials